Indian-American physician leads 'Project Asha' for oncology clinical trials in India
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Source: theweek.in
Oncologic Diseases News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oncologic Diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oncologic Diseases Today - Breaking & Trending Today
NCCN Adds Nirogacestat to Guidelines for Patients With Soft Tissue Sarcoma
The NCCN has updated their guidelines for soft tissue sarcoma to include the γ-secretase inhibitor nirogacestat as a systemic therapy option for patients with desmoid tumors, granting the agent a preferred, category 1 recommendation.
Source: onclive.com
FDA Approves Nirogacestat for Treatment of Desmoid Tumors
Desmoid tumors are noncancerous growths that appear in connective tissue, most often on the arms, legs, and abdomen. Aggressive tumors must be treated with surgery, radiation, or chemotherapy to keep them from growing into nearby organs, which can make them life-threatening. They can cause pain and disfigurement, and they can reduce functioning and quality of life.
Source: ajmc.com
FDA Approves Nirogacestat Tablets for Rare Desmoid Tumors
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.
Source: hcplive.com
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
The FDA approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Nirogacestat is a new molecular entity and the first drug to be approved for the treatment of patients with desmoid tumors, a subtype of soft tissue sarcomas.
Source: fda.gov